pyrazolanthrone has been researched along with Bone Cancer in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, X; Zhu, S | 1 |
| Ji, G; Li, Z; Lin, B; Liu, W; Wang, S; Wei, G; Xue, X; Yu, N | 1 |
| Gu, R; Li, Q; Liu, Y; Lu, P; Wu, X; Yan, L; Yu, X; Zhang, Y; Zhu, D; Zou, J | 1 |
| Chang, SL; Fong, YC; Hsu, CJ; Lin, CY; Tang, CH | 1 |
| Gweon, EJ; Kim, SJ | 1 |
| Hou, M; Shi, Q; Wang, H; Weng, Y; Yan, S; Yao, J; Zuo, G | 1 |
| Du, X; Huang, Q; Li, K; Ou, Y; Tao, Y; Tu, P; Yin, H | 1 |
| Bai, L; Cai, GH; Guo, CH; Ma, W; Wang, X; Wu, HH; Wu, SX; Yang, J | 1 |
| Chen, F; James, AW; Soo, C; Soofer, DE; Ting, K; Walder, B; Zhang, X | 1 |
| Fromigué, O; Marie, PJ; Modrowski, D; Orosco, A; Thévenard, J | 1 |
10 other study(ies) available for pyrazolanthrone and Bone Cancer
| Article | Year |
|---|---|
Prognosis-related VDAC1 regulates the proliferation and apoptosis of osteosarcoma cells via the MAPK signaling pathway.
Topics: Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Humans; Osteosarcoma; Prognosis; Signal Transduction; Voltage-Dependent Anion Channel 1 | 2023 |
Acacetin Induces Apoptosis in Human Osteosarcoma Cells by Modulation of ROS/JNK Activation.
Topics: Anthracenes; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flavones; Humans; JNK Mitogen-Activated Protein Kinases; Osteosarcoma; Reactive Oxygen Species | 2020 |
Andrographolide Induces Autophagic Cell Death and Inhibits Invasion and Metastasis of Human Osteosarcoma Cells in An Autophagy-Dependent Manner.
Topics: Anthracenes; Apoptosis; Autophagy; Beclin-1; Bone Neoplasms; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Proliferation; Diterpenes; Humans; JNK Mitogen-Activated Protein Kinases; Oligopeptides; Osteosarcoma; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA Interference; RNA, Small Interfering; Signal Transduction; TOR Serine-Threonine Kinases | 2017 |
Apoptosis signal-regulating kinase 1 is involved in brain-derived neurotrophic factor (BDNF)-enhanced cell motility and matrix metalloproteinase 1 expression in human chondrosarcoma cells.
Topics: Anthracenes; Bone Neoplasms; Brain-Derived Neurotrophic Factor; Carbazoles; Cell Line, Tumor; Cell Movement; Chondrosarcoma; Humans; Imidazoles; Indole Alkaloids; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 5; Matrix Metalloproteinase 1; Neoplasm Invasiveness; Neoplasm Metastasis; p38 Mitogen-Activated Protein Kinases; Prognosis; Protein Kinases; Pyridines; Receptor, trkB; Signal Transduction; Thioredoxins; Up-Regulation | 2013 |
Resveratrol attenuates matrix metalloproteinase-9 and -2-regulated differentiation of HTB94 chondrosarcoma cells through the p38 kinase and JNK pathways.
Topics: Anthracenes; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Cell Differentiation; Cell Line, Tumor; Chondrosarcoma; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Pyridines; Resveratrol; Stilbenes | 2014 |
NOV inhibits proliferation while promoting apoptosis and migration in osteosarcoma cell lines through p38/MAPK and JNK/MAPK pathways.
Topics: Anthracenes; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Nephroblastoma Overexpressed Protein; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines | 2015 |
Aloe-emodin-mediated photodynamic therapy induces autophagy and apoptosis in human osteosarcoma cell line MG‑63 through the ROS/JNK signaling pathway.
Topics: Acetylcysteine; Anthracenes; Anthraquinones; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Osteosarcoma; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species | 2016 |
The analgesic effect of rolipram is associated with the inhibition of the activation of the spinal astrocytic JNK/CCL2 pathway in bone cancer pain.
Topics: Analgesics; Animals; Anthracenes; Astrocytes; Bone Neoplasms; Cancer Pain; Chemokine CCL2; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Female; Hyperalgesia; Inflammation Mediators; Injections, Spinal; JNK Mitogen-Activated Protein Kinases; Neurons; Phosphorylation; Rats, Sprague-Dawley; Rolipram; Signal Transduction; Spinal Cord; Up-Regulation | 2016 |
NELL-1-dependent mineralisation of Saos-2 human osteosarcoma cells is mediated via c-Jun N-terminal kinase pathway activation.
Topics: Anthracenes; Bone Neoplasms; Calcification, Physiologic; Calcium Phosphates; Calcium Signaling; Calcium-Binding Proteins; Cell Differentiation; Cell Line, Tumor; Enzyme Activation; Enzyme Inhibitors; Humans; JNK Mitogen-Activated Protein Kinases; Nerve Tissue Proteins; Osteocytes; Osteosarcoma; Recombinant Proteins | 2012 |
Syndecan-2 overexpression induces osteosarcoma cell apoptosis: Implication of syndecan-2 cytoplasmic domain and JNK signaling.
Topics: Anthracenes; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Membrane Glycoproteins; Mutation; Osteoblasts; Osteosarcoma; Phosphorylation; Protein Structure, Tertiary; Proteoglycans; Signal Transduction; Syndecan-2 | 2005 |